Purchase Order 36C24226P0119
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for TARPEYO 4mg (budesonide), a specialty pharmaceutical product used to treat immunoglobulin A nephropathy in veterans. The contract, valued at $10,896.98, was awarded on November 10, 2025, with an ultimate completion date of December 10, 2025. The award carries no set-aside designation and will be...
- The Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) awarded an emergency purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on September 11, 2025, for the supply of TARPEYO 4mg (budesonide) for the New York Harbor area. This firm fixed-price purchase order, valued at $10,896.98, represents an emergency procurement with a completion date of November 1, 2025. Pantherx Specialty Pharmacy, a Pittsburgh, Pennsylvania-based...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO 4MG, a specialized pharmaceutical product, to the VA's New York Harbor healthcare system. The contract has a ceiling value of $10,896.98 and a period of performance through July 31, 2025. The contract does not have a set-aside designation. Pantherx...
- This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
- This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
- The Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) awarded a $30,275.65 firm fixed-price purchase order to Pantherx Specialty, LLC on September 16, 2025, for emergency pharmaceutical products. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, and will be performed at the contractor's location in Pittsburgh, Pennsylvania. Pantherx Specialty, LLC, operating as Pantherx Specialty Pharmacy and a subsidiary of...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for the provision of TARPEYO medication, valued at $10,896.98. This contract, awarded on November 4, 2025, carries an ultimate completion date of December 31, 2025, and includes no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania, where the prime contractor is headquartered. Pantherx Specialty, a for-profit limited liability company and subsidiary of Centene Corporation, specializes in rare disease and customized pharmaceutical solutions. This award represents a continuation of the ongoing relationship between Pantherx Specialty and VISN 2, the regional Veterans Health Administration network serving veterans in the northeastern United States. TARPEYO (budesonide) is a specialty medication used to treat immunoglobulin A nephropathy, a kidney disease affecting veterans and other patient populations. As a registered specialty pharmacy provider, Pantherx Specialty has consistently delivered emergency and specialized prescription medications to federal healthcare agencies, particularly the VA and Department of Justice, through similar firm fixed-price purchase orders. This contract supports the VA's mission to provide comprehensive health services to eligible veterans through its regional network infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 11/5/25 |